113 related articles for article (PubMed ID: 10827245)
1. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
Patel R
Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
[No Abstract] [Full Text] [Related]
2. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
Winston DJ; Pakrasi A; Busuttil RW
Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic fluconazole in liver transplant recipients.
Singh N; Yu VL
Ann Intern Med; 2000 May; 132(10):843-4. PubMed ID: 10819716
[No Abstract] [Full Text] [Related]
6. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Burgaleta C
Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
[No Abstract] [Full Text] [Related]
8. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
Muñoz P; Bouza E
Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
[No Abstract] [Full Text] [Related]
9. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.
Shorr AF; Chung K; Jackson WL; Waterman PE; Kollef MH
Crit Care Med; 2005 Sep; 33(9):1928-35; quiz 1936. PubMed ID: 16148461
[TBL] [Abstract][Full Text] [Related]
10. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
Mossad SB; Avery RK; Bolwell BJ
Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853
[No Abstract] [Full Text] [Related]
11. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.
Ho KM; Lipman J; Dobb GJ; Webb SA
Crit Care; 2005; 9(6):R710-7. PubMed ID: 16280069
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
14. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Vardakas KZ; Michalopoulos A; Falagas ME
Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
[TBL] [Abstract][Full Text] [Related]
16. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
Long SS; Stevenson DK
J Pediatr; 2005 Aug; 147(2):135-41. PubMed ID: 16126036
[No Abstract] [Full Text] [Related]
17. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
Corvò R; Amichetti M; Ascarelli A; Arcangeli G; Buffoli A; Cellini N; Cionini L; De Renzis C; Emiliani E; Franchini P; Gabriele P; Gobitti C; Grillo Ruggieri F; Bertoni F; Magrini SM; Marmiroli L; Orsatti M; Panizza GM; Tordiglione M; Ziccarelli L; Gava A; Zorat PL; Ghelfi R; Serra GF; Vitale V
Eur J Cancer Care (Engl); 2008 May; 17(3):270-7. PubMed ID: 18419630
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of fungal infections.
Schuler US; Haag C
Mycoses; 1997; 40 Suppl 2():41-4. PubMed ID: 9476504
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole prophylaxis for high-risk liver transplant recipients.
Kung N; Fisher N; Gunson B; Hastings M; Mutimer D
Lancet; 1995 May; 345(8959):1234-5. PubMed ID: 7739317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
